A target-specific cellular assay for screening of topoisomerase I inhibitors

Journal of Biomolecular Screening

Volumn 4, Issue 2, 1999, Pages 93-100

  Spaltmann, Frank ^a   Lohrmann, Emanuel ^b   Ziegelbauer, Karl ^a,c  

^a BAYER AG   (Germany)

^b Molekulare Screening Technologie   (Germany)

^c BAYER YAKUHIN LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; FLUORESCENT DYE; GREEN FLUORESCENT PROTEIN;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOASSAY; CELL DENSITY; DELETION MUTANT; DNA SUPERCOILING; DRUG SCREENING; DRUG TARGETING; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE MICROSCOPY; FUNGUS GROWTH; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REPORTER GENE; SACCHAROMYCES CEREVISIAE; STRAIN DIFFERENCE;

FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 0033066511     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705719900400209     Document Type: Article

References (17)

1. Ryley, J.F., Barrett-Bee, K. (1992). Screening for antifungal activity. In Emerging Targets in Antibacterial and Antifungal Chemotherapy. J.A. Sutcliffe, and N.H. Georgopapadakou (eds.), pp. 546-567. Chapman and Hall, New York.
2. Como, J.A., Dismukes, W.E. (1994). Oral azole drugs as systemic antifungal therapy. N Engl. J. Med. 330:263-272.
3. Mayor, J.S. (1996). High-throughput biochemical screening: advantages and disadvantages. In Antifungal Agents, Discovery and Mode of Action. G.K. Dixon, C.G. Coppong, D.W. Holloman (eds.), pp. 9-16. Bios. Sci. Publ. Ltd., Oxford.
4. Timberlake, W.E. (1995). Cellular reporters for antifungal drug discovery. In Antifungal Agents. Discovery and Mode of Action. G.K. Dixon, C.G. Coppong, D.W. Holloman (eds.), pp. 17-29. Bios. Sci. Publ. Ltd., Oxford.
5. Sutcliffe, J.A., Gootz, T.D., Barrett, J.F. (1989). Biochemical characteristics and physiological significance of major DNA topoisomerases. Antimicrob. Agents Chemother. 33:2027-2033.
6. Trash, C., Bankier, A.T., Barrell, B.G., Stemglanz, R. (1985). Cloning, characterization, and sequence of the yeast DNA topoisomerase I gene. Proc. Natl. Acad. Sci. USA 82:4374-4378.
7. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., Prashner, D.C. (1994). Green fluorescent protein as a marker for gene expression. Science 263:802-805.
8. Inouye, S., Tsuji, F.I. (1994). Aequorea green fluorescent protein - Expression of the gene and fluorescence characteristics of the recombinant protein. FEBS Lett 341:277-280.
9. Clontech (1996) Living Colors TM GFP Application Notes.
10. Niedenthal, R.K., Riles, L., Johnston, M., Hegemann, J.H. (1996). Green fluorescent protein as a marker for gene-expression and subcellular localization in budding yeast. Yeast 12:773-786.
11. Atkins, D., Izant, J.G. (1996). Expression and analysis of the green fluorescent protein gene in the fission yeast Schizosaccharomyces pombe. Curr. Genet. 28:585-588.
12. Heim, R., Prashner, D.C., Tsien, R.Y. (1994). Wavelength mutations and posttranslational autooxidation of green fluorescent protein. Proc. Natl. Acad. Sci. USA 91:12501-12504.
13. Delagrave, S., Hawtin, R.E., Silva, C.M., Yang, M.M., Youvyn, D.C. (1995). Red-shifted excitation mutants of the green fluorescent protein. Bio/technology 13:151-154.
14. Heim, R., Tsien, R.Y. (1996). Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr. Biol. 6:178-182.
15. Crameri, A., Whitehorn, E.A., Tate, E., Stemmer, W.P.C. (1996). Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat. Biotech. 14:315-319.
16. Cormack, B., Valdivia, R.H., Falkow, S. (1996). FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38.
17. Heim, R., Cubitt, A.B., Tsien, R.Y. (1995). Improved green fluorescence. Nature 373:663-664.